HCPLive Network

Low-T

Stendra (avanafil) is now the only FDA-approved erectile dysfunction (ED) medication indicated to be taken as early as approximately 15 minutes before sexual activity.
Staff scientists at the US Food and Drug Administration (FDA) have concluded that there’s no “convincing evidence” linking testosterone replacement therapy with adverse cardiovascular events.
A new study showing significant negative correlation between phthalate absorption and testosterone levels adds considerably more weight and significant new details to a growing body of research.
There is little evidence that testosterone drugs are either beneficial or pose serious health risks to men, the U.S. Food and Drug Administration says in a review posted online Wednesday.
A common treatment for opioid addiction significantly reduces testosterone levels in many male patients; researchers suggest that supplementary testosterone might improve outcomes.
Opioid treatment suppressed testosterone levels in men, yet the therapy left women’s testosterone levels unaltered, according to a study in Scientific Reports.
Low-T Upcoming Events
Low-T Latest News
Low-T Clinical Trials
Low-T Resources